This public procurement record has 3 releases in its history.

Award

10 Sep 2026 at 12:57

Award

17 Aug 2026 at 14:48

Award

17 Aug 2026 at 14:41

Summary of the contracting process

Northern Health and Social Care Trust procured the supply of secukinumab (Cosentyx) in 150mg and 300mg pre-filled pens and syringes, provided through a homecare service. This is a pharmaceutical goods requirement supporting patient treatment and continuity of care. Delivery is for patients supported by the Trust in Northern Ireland. The buyer is Northern Health and Social Care Trust, based in Antrim. The requirement covers the named medicine rather than a broad medicines portfolio, so it is most relevant to pharmaceutical manufacturers, authorised medicine suppliers and specialist homecare providers with the capability to supply secukinumab in the specified presentations and support its delivery to patients. The contract description states that the medicine is required specifically for homecare support.

The procurement has been awarded and the tender is complete. Northern Health and Social Care Trust used a direct award to Sciensus Pharma Services Limited, on the basis that technical reasons and patent protection or sole marketing authorisation meant there was no competition, reasonable substitute or alternative supplier. The award date was 17 August 2026. The contract was signed on 10 September 2026 and runs from 1 September 2026 to 31 August 2029. The awarded value is £4,000,000 excluding VAT and £4,800,000 including VAT. There was one completed lot. The award is active and the contract is active. The selected supplier is Sciensus Pharma Services Limited. The requirement was treated as above the relevant threshold.

For suppliers that did not win, this award confirms a defined demand from Northern Health and Social Care Trust for secukinumab supplied through homecare, with a substantial multi-year requirement focused on continuity of patient care. A credible future competitor would need to supply Cosentyx in both 150mg and 300mg pre-filled pen or syringe presentations and provide a dependable homecare route to patients. The procurement also shows that the buyer considered the medicine subject to patent protection and held that only a particular supplier could provide it, with no reasonable substitute. Businesses would therefore need a strong position in the authorised supply chain for this named medicine, together with the operational capability to maintain uninterrupted patient supply through homecare. General pharmaceutical or logistics capability alone would not match the stated requirement.

How relevant is this notice?

Notice Information

Notice Title

SECUKINUMAB (COSENTYX) 150 mg and 300mg Pre-filled Pen and Syringes via homecare

Notice Description

Contract for supply of SECUKINUMAB (COSENTYX) 150 mg and 300mg Pre-filled Pen and Syringes via homecare for a period of up to 3 years

Procurement Information

Single supplier - technical reasons Section 41 schedule 5(6) of the PA2023 permits a direct award if the following conditions are met in relation to the public contract: (a)due to an absence of competition for technical reasons, only a particular supplier can supply the goods, services or works required, and (b)there are no reasonable alternatives to those goods, services or works. The Northern Health and Social Care Trust requires the purchase of Secukinumab which is subject to patent protection / Sole MA Holder and consequently no reasonable alternative of substitute exists. These essential medicines are required from this supplier to ensure continuity of patient care, specifically for homecare support. The absence of competition is not the artificial narrowing of the parameters of the procurement.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06e5b6
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/085866-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£4,000,000 £1M-£10M
Contracts Value
£4,000,000 £1M-£10M

Notice Dates

Publication Date
10 Sep 20261 months ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
17 Aug 20262 months ago
Contract Period
10 Sep 2026 - 31 Aug 2029 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Northern Health and Social Care Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
ANTRIM
Postcode
BT41 2RL
Postcode Area
Northern Ireland
Country
Northern Ireland

Major Region (ITL 1)
TLN Northern Ireland
Basic Region (ITL 2)
TLN0 Northern Ireland
Small Region (ITL 3)
TLN0D Antrim and Newtownabbey
Delivery Location
Not specified

Local Authority
Antrim and Newtownabbey
Electoral Ward
Springfarm
Westminster Constituency
South Antrim

Supplier Information

Number of Suppliers
1
Supplier Name

SCIENSUS PHARMA SERVICES LIMITED

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...